Li, Y. (2025). Sintilimab plus bevacizumab, oxaliplatin, and capecitabine as perioperative therapy in microsatellite-stable, resectable colorectal cancer liver metastases: An open-label, single-arm, phase II trial.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.3586